Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bristol-Myers Squibb (NY: BMY ) 44.03 +0.13 (+0.30%) Streaming Delayed Price Updated: 11:32 AM EDT, May 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Bristol-Myers Squibb < Previous 1 2 3 4 5 6 7 8 9 ... 41 42 Next > Got $5,000? These 3 Stocks Are Dirt Cheap Buys With Plenty of Upside February 21, 2024 Shares of these companies are trading at sizable earnings discounts. Via The Motley Fool Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes February 20, 2024 Cannabis multi-state operator Cresco Labs kicked off February by announcing the promotion of Greg Butler to the position of president. Tom Shuman, a CPG sales and marketing veteran, agreed to serve as... Via Benzinga Topics Cannabis Exposures Cannabis Is It Too Late to Buy These 2 Brilliant Passive Income Stocks? February 17, 2024 Patience will be rewarded with these stocks. Via The Motley Fool 7 Contrarian Biotech Stocks to Consider Amid Sector Weakness February 15, 2024 Although the healthcare innovation space has struggled recently, these contrarian biotech stocks now offer compelling discounts. Via InvestorPlace Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb February 09, 2024 Via Benzinga Bristol-Myers Squibb Options Trading: A Deep Dive into Market Sentiment February 05, 2024 Via Benzinga Bristol-Myers Squibb's Earnings Outlook February 01, 2024 Via Benzinga Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields February 14, 2024 During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... Via Benzinga A Look At Pharma ETFs After Q4 Earnings February 12, 2024 The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. Via Talk Markets Topics ETFs 7 Dividend Stocks to Buy at a 52-Week Low February 12, 2024 Each of these dividend stocks has been down sharply in the last 12 months but has fundamental reasons that support a turnaround. Via InvestorPlace Bernie Sanders Blasts Big Pharma's Pricing Of Lifesaving Drugs In US During Senate Hearing On Medicare February 09, 2024 Via Benzinga 7 Biotech Stocks Fighting America’s Deadliest Diseases February 08, 2024 Although the human condition can be alarmingly frail at times, these groundbreaking biotech stocks are aiming to right the ship. Via InvestorPlace How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month February 08, 2024 Cytokinetics is looking to take on Bristol Myers Squibb in treating a heart disease. Via Investor's Business Daily 3 Blue-Chip Stocks to Buy at a 52-Week Low in February February 07, 2024 Higher-for-longer interest rates and undervalued metrics make it a good time to look for blue-chip stocks at a low price. Via InvestorPlace UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst February 06, 2024 UBS bullish on Axsome's Auvelity launch and pipeline, foreseeing $1 billion sales by 2030. Buy rating, $111 price target. Positive Phase 3 data for Alzheimer's Agitation and Narcolepsy. Via Benzinga Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday February 06, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga Undervalued Gems: 7 Stocks Set for a Major Rebound February 05, 2024 Each of these seven undervalued stocks has fallen by 25% or more from its 52-week high, but may have a path back to prior prices. Via InvestorPlace 3 Blue Chip Dividend Stocks To Play Defense February 02, 2024 We will discuss 3 long-term blue chip stocks to play defense. They have raised their dividends each year for over ten years, have current yields above the S&P 500 Index average, and should continue to... Via Talk Markets Topics Stocks Exposures US Equities Bristol Myers Squibb (BMY) Q4 2023 Earnings Call Transcript February 02, 2024 BMY earnings call for the period ending December 31, 2023. Via The Motley Fool Topics Earnings Exposures Financial Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations February 02, 2024 The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system. Via Benzinga Topics Economy Exposures Interest Rates Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review February 02, 2024 The Dow led the major indexes higher. Big techs diverged on results. Via Investor's Business Daily Topics Economy Stocks Exposures Interest Rates US Equities What's Going On With US Pharma Giant Bristol-Myers Squibb Stock Today? February 02, 2024 Bristol Myers Squibb reports Q4 revenues of $11.48 billion, up 1% YoY. Eliquis and Opdivo sales drive growth, offsetting Revlimid decline. Via Benzinga Bristol Myers Shares Rise On Fourth-Quarter Earnings Beat February 02, 2024 Bristol Myers earnings came in above expectations, although Opdivo sales were slower than expected. BMY stock gained. Via Investor's Business Daily Nasdaq Futures Climb As Meta, Amazon Gains Offset Apple Slide: Analyst Points to 2 Factors Reinforcing Bullish Outlook This Year February 02, 2024 Stock futures are pointing upwards on Friday as traders assess earnings reports from Meta Platforms, Inc. Via Benzinga Earnings Scheduled For February 2, 2024 February 02, 2024 Companies Reporting Before The Bell • W.W. Grainger (NYSE:GWW) is likely to report quarterly earnings at $8.05 per share on revenue of $4.04 billion. Via Benzinga Investor Optimism Improves Following Earnings, Economic Reports; Dow Jumps Over 350 Points February 02, 2024 The CNN Money Fear and Greed index showed an increase in the overall market sentiment, but the index remained in the "Greed" zone on Thursday. Via Benzinga Topics Stocks Exposures US Equities Amazon, Apple And 3 Stocks To Watch Heading Into Friday February 02, 2024 With U.S. stock futures trading mostly higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: Via Benzinga BMY Stock Dividend Delight: A Blue-Chip’s Healthy Yield January 31, 2024 In the grand theater of the financial markets, Bristol-Myers Squibb stands out as a robust performer. Despite the recent pullback, the market sentiment towards this biopharmaceutical titan remains... Via Talk Markets Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60% January 30, 2024 Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions. Via Benzinga Did You Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts? January 30, 2024 During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 41 42 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.